DouglasEarlLauxMD

PubMed

• 1 citations
  Time to put it out - nurse-facilitated tobacco treatment in a comprehensive cancer center.
  David A. Katz, Sarah L. Mott, Jane A Utech, Autumn C Bahlmann, Kimberly A Dukes, Aaron T Seaman, Douglas E Laux, Muhammad Furqan, Zachary J Pollock, Mark W. Vander Weg> ;Translational Behavioral Medicine. 2021 Sep 15
• 1 citations
  High-specific-activity 131 iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.
  Joseph S. Dillon, David L. Bushnell, Douglas E Laux> ;Future Oncology. 2021 Jan 28
• 1 citations
  A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
  Tatiana Correa, Douglas E Laux, Henry T. Hoffman> ;Clinical Case Reports. 2021 Jan 1
• 24 citations
  Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
  Madelyn Espinosa-Cotton, Samuel N. Rodman, Kathleen A. Ross, Isaac J. Jensen, Kenley Sangodeyi-Miller, Katherine N. Gibson-Corley, Adam T. Koch, Yang Xin Fu, Vladimir ...> ;Journal for Immunotherapy of Cancer. 2019 Dec 1
• 6 citations
  A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab
  Madelyn Espinosa-Cotton, Elana J. Fertig, Laura P. Stabile, Autumn Gaither-Davis, Julie E. Bauman, Sandra Schmitz, Katherine N. Gibson-Corley, Yinwen Cheng, Isaac J. J...> ;Biomarker Research. 2019 Jul 16
• 4 citations
  Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous...
  Muhammad Furqan, Travis Snyders, Mohammed U Saqlain, Sarah L. Mott, Douglas Earl Laux, Anthony N. Snow, Carryn M. Anderson, J.M. Watkins, Gerald H. Clamon> ;Cancer Medicine. 2019 Apr 9
• 2 citations
  A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers.
  Jill M. Kolesar, Shannon Andrews, Heather A. Green, Thomas C. Havighurst, Barbara W. Wollmer, Katina DeShong, Douglas E Laux, Helen Krontiras, Donald D. Muccio, KyungM...> ;Cancer Prevention Research. 2019 Jan 1
• 50 citations
  Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
  Chang Xia, Roberto A. Leon-Ferre, Douglas Earl Laux, Jeremy Deutsch, Brian J. Smith, Melanie Frees, Mohammed M. Milhem> ;Cancer Chemotherapy and Pharmacology. 2014 Jul 26
• 34 citations
  Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway
  Liang Zhang, Phil Karp, Christopher J. Gerard, Eric Pastor, Douglas E. Laux, Keith Munson, Ziying Yan, Xiaoming Liu, Simon Godwin, Christie P. Thomas, Joseph Zabner, H...> ;Molecular Therapy. 2004 Dec 1
• 124 citations
  CpG Island Arrays: An Application toward Deciphering Epigenetic Signatures of Breast Cancer
  Pearlly S. Yan, Martin R. Perry, Douglas E. Laux, Adam L. Asare, Charles W. Caldwell, Tim H M Huang> ;Clinical Cancer Research. 2000 Apr 1
• 32 citations
  Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas.
  Douglas E. Laux, Edward M. Curran, Wade V. Welshons, Dennis B. Lubahn, Tim H M Huang> ;Breast Cancer Research and Treatment. 1999 Jul 1
• 314 citations
  Methylation Profiling of CpG Islands in Human Breast Cancer Cells
  Tim H M Huang, Martin R. Perry, Douglas E. Laux> ;Human Molecular Genetics. 1999 Mar 1
• 93 citations
  Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
  Tim H M Huang, Douglas E. Laux, Brian C. Hamlin, Phuong Tran, Hoa Tran, Dennis B. Lubahn> ;Cancer Research. 1997 Mar 15
• Join now to see all